IBD: Clinical Trials

2 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	2	Terminated 2
Phase 3	1	Terminated 1

Follow IBD: new trials by email Literature Review of IBD trials Research Report on IBD

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease Brazikumab low dose, Brazikumab high dose, Humira® - Crohn's Disease, IBD	Phase 2 / Phase 3	Terminated	AstraZeneca	89	2018-12-07	2026-06-23
Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis Brazikumab, Placebo - Ulcerative Colitis, IBD	Phase 2	Terminated	AstraZeneca	242	2018-08-07	2026-06-23

Narrower conditions

Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Inflammatory Bowel Diseases (1)

Broader conditions

Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Colitis (1)  ·  Colonic Diseases (1)  ·  Inflammatory Bowel Diseases (1)

Interventions

Adalimumab (1)

Sponsors

AstraZeneca (2)

Countries

Canada (2)  ·  Czechia (2)  ·  Germany (2)  ·  Hungary (2)  ·  India (2)  ·  Israel (2)  ·  Italy (2)  ·  Poland (2)  ·  Russia (2)  ·  Slovakia (2)  ·  South Africa (2)  ·  South Korea (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Ukraine (2)

Top investigators

Kathy Bohannon (2)

NIH funding

2018 (2)